News

Nuvo’s president and CEO Jesse Ledger said: “The close of this transaction positions Nuvo as one of the premier specialty pharmaceutical companies in Canada. “Nuvo is now truly

Antengene has secured the money under series B financing round led by Boyu Capital and FountainVest. The participants include new investors such as Celgene, WuXi Corporate Venture Fund

Andexxa received both U.S. Orphan Drug and FDA Breakthrough Therapy designations and was initially approved on May 3, 2018 under the FDA’s Accelerated Approval pathway. It is the

The dug will be produced at the group’s Topical manufacturing facility at Ahmedabad in Gujarat, India. This combination medication, according to the pharma company, is used to treat

The vaccine, called Vaxelis, is indicated to prevent diphtheria, tetanus, poliomyelitis, pertussis, hepatitis B and invasive disease due to Haemophilus influenzae type b. It has been approved for

ACO is commonly associated with the ingestion of ‘edibles’ such as brownies, cookies and candies that contain large quantities of  D9-tetrahydrocannabinol (THC) and synthetic cannabinoids that are more

The FDA will review the NDA for KPI-121 0.25%, which is designed to provide temporary relief to the signs and symptoms of dry eye disease, including dry eye

PCOS is the most common endocrine disorder found in reproductive-age women, and is a major cause of infertility and type 2 diabetes. The source of the disease is

Scars caused by eye infection or trauma convert the usually transparent cornea into an opaque state, thereby leading to blurred vision or complete blindness. Compared with existing standard